Production (Stage)
Sagimet Biosciences Inc.
SGMT
$3.50
$0.102.94%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.52M | 3.98M | 4.25M | 4.28M | 3.51M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.87M | 18.20M | 16.90M | 10.59M | 8.77M |
| Operating Income | -19.87M | -18.20M | -16.90M | -10.59M | -8.77M |
| Income Before Tax | -18.18M | -16.20M | -14.62M | -8.12M | -6.63M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -18.18M | -16.20M | -14.62M | -8.12M | -6.63M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.18M | -16.20M | -14.62M | -8.12M | -6.63M |
| EBIT | -19.87M | -18.20M | -16.90M | -10.59M | -8.77M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.56 | -0.50 | -0.45 | -0.25 | -0.23 |
| Normalized Basic EPS | -0.35 | -0.31 | -0.28 | -0.16 | -0.14 |
| EPS Diluted | -0.56 | -0.50 | -0.45 | -0.25 | -0.23 |
| Normalized Diluted EPS | -0.35 | -0.31 | -0.28 | -0.16 | -0.14 |
| Average Basic Shares Outstanding | 32.20M | 32.20M | 32.14M | 31.91M | 29.04M |
| Average Diluted Shares Outstanding | 32.20M | 32.20M | 32.14M | 31.91M | 29.04M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |